Autopsy report · NCT04232878

A Single Ascending Dose Trial of CVL-936 in Healthy Subjects

“Sufficient data has been obtained to meet current objectives”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 5 months before it stopped.
• 10 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Cerevel Therapeutics, LLC

Sponsor type

Industry

Conditions

Substance Use Disorders (SUD)

Interventions

CVL-936; Matching Placebo

Participants

10

Sites

1

Countries

United States

Trials that died the same way

• Prevalence and Clinical Spectrum of the 22q11 Deletion
  “sufficient data collected” (78% match in meaning)
• Feeding After Neonate Surgery Review
  “sufficient data gathered for study conclusion” (69% match in meaning)
• A Study of the Safety and Efficacy of MK-3577 in Participants With Type 2 Diabetes Mellitus (MK-3577-009)
  “Upon interim analysis, sufficient data was accrued to assess study hypotheses.” (57% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.